Episode 487
What's Wrong With Government Limiting The Cost Of Your Meds?
Andrew Lautz from the National Taxpayers Union says the economics of controlling drug prices is complex and warns against mandates that cap those costs. Among the concerns is that a government limit on prices for consumers will likely slow down the development of new medicines.
American Viewpoints · Andrew Lautz, Mike Ferguson
March 22, 202310m 2s
Audio is streamed directly from the publisher (cdn.simplecast.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Andrew Lautz from the National Taxpayers Union says the economics of controlling drug prices is complex and warns against mandates that cap those costs. Among the concerns is that a government limit on prices for consumers will likely slow down the development of new medicines.
Topics
andrew lautznational taxpayers unionmedicationntupharmaceuticalhealth caremedicine